Safety of Favipiravir in Mild and Moderately Ill Indonesian COVID-19 Patients

Introduction: Favipiravir is one of the antivirals that has received Emergency Use Authorization (EUA) for COVID-19 therapy by regulators in many countries, including Indonesia. The Indonesian Guideline for the Management of COVID-19 Editions 1, 2, and 3 recommend favipiravir as the antiviral of cho...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Drug safety 2023-11, Vol.46 (11), p.1221-1222
Hauptverfasser:	Sauriasari, R, Chrisdy, I M, Munjiyah, M, Kusumawardani, L A, Rahmasari, R
Format:	Artikel
Sprache:	eng
Schlagworte:	Algorithms Antiviral agents Constipation COVID-19 Diarrhea Hyperuricemia Insomnia Leukocytes (neutrophilic) Medical records Nausea Oseltamivir Pain Patients Population studies Safety Side effects Sleep disorders Transaminase Vomiting
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!